FDA inspection
SPI Pharma, Inc.: FDA inspection ending Nov 19, 2013
FDA inspection 860789 · Voluntary Action Indicated (VAI) · Grand Haven, MI
Key facts
| Inspection ID | 860789 |
|---|---|
| Firm | SPI Pharma, Inc. |
| FEI number | 1833292 |
| Address | 1711 Tiles Ct |
| City | Grand Haven |
| State | MI |
| ZIP | 49417 |
| Country | United States |
| Fiscal year | 2014 |
| Inspection end date | Nov 19, 2013 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data